Stage 3 Type 1 Diabetes Mellitus
Drug | Drug Name | Drug Description |
---|---|---|
DB06606 | Teplizumab | A CD3-directed monoclonal antibody indicated to delay the onset of Stage 3 type 1 diabetes in patients with Stage 2 type 1 diabetes. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06606 | Teplizumab | T-cell surface glycoprotein CD3 epsilon chain | target |
Drug | Drug Name | Phase | Status | Count |
---|